PharmStockPharmacy Stock

Emsam
Emsam

2.42
A generic medicine indicated for mental health conditions. Modulates neurotransmitter levels to address mood disturbances and emotional regulation challenges.
Ingredient
Selegiline
Category
Antidepressants
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Selegiline
Reference Brand
Selegiline
Product Origin
Generic Alternative
Reference Manufacturer
Somerset Pharmaceuticals
Product Form
Transdermal Patch
Regulatory Classification
Prescription Only Medicine
Primary Category
Antidepressants
Product Category
Monoamine Oxidase Inhibitor (MAOI)
Pharmacological Class
Antidepressant
Clinical Indications
Major depressive disorder
Manufacturer Description
Developed to mitigate severe depressive symptoms to support psychiatric recovery and target monoamine neurotransmitters.
Mechanism of Action
Inhibits central MAO-A and MAO-B enzymes, raising concentrations of dopamine, norepinephrine, and serotonin in the brain.
Route of Administration
Transdermal
Onset Time
1–2 weeks
Duration
24 hours
Contraindications
Pheochromocytoma, Concurrent use of other antidepressants, Severe hepatic impairment
Severe Adverse Events
Hypertensive crisis — requires immediate medical attention, Serotonin syndrome — requires immediate medical attention
Common Side Effects
Application site reaction, Headache, Insomnia
Uncommon Side Effects
Diarrhea, Dry mouth, Orthostatic hypotension
Drug Interactions
Antidepressants, Sympathomimetics, Tyramine-rich foods
Pregnancy Safety Warnings
TGA Category C: Use if potential benefits outweigh risks. Breastfeeding: Consult a clinician.
Age Restrictions
Approved for adults over eighteen years.
Storage Guidelines
Store below 25°C.
Related Products
Eldepryl
Information related to Emsam is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to access Migraine & Epilepsy Medication - Duloxetine Neuropathic Pain SNRI